These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 25231973)

  • 1. Raloxifene inhibits cloned Kv4.3 channels in an estrogen receptor-independent manner.
    Chae YJ; Kim DH; Lee HJ; Sung KW; Kwon OJ; Hahn SJ
    Pflugers Arch; 2015 Aug; 467(8):1663-76. PubMed ID: 25231973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of MiRP1 and DPP6 beta-subunits on the blockade induced by flecainide of Kv4.3/KChIP2 channels.
    Radicke S; Vaquero M; Caballero R; Gómez R; Núñez L; Tamargo J; Ravens U; Wettwer E; Delpón E
    Br J Pharmacol; 2008 Jun; 154(4):774-86. PubMed ID: 18536731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional modulation of the transient outward current Ito by KCNE beta-subunits and regional distribution in human non-failing and failing hearts.
    Radicke S; Cotella D; Graf EM; Banse U; Jost N; Varró A; Tseng GN; Ravens U; Wettwer E
    Cardiovasc Res; 2006 Sep; 71(4):695-703. PubMed ID: 16876774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of mosapride on Kv4.3 potassium channels expressed in CHO cells.
    Sung KW; Hahn SJ
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Oct; 386(10):905-16. PubMed ID: 23793103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Kv4.3 by genistein via a tyrosine phosphorylation-independent mechanism.
    Kim HJ; Ahn HS; Choi BH; Hahn SJ
    Am J Physiol Cell Physiol; 2011 Mar; 300(3):C567-75. PubMed ID: 21148405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of haloperidol on Kv4.3 potassium channels.
    Lee HJ; Sung KW; Hahn SJ
    Eur J Pharmacol; 2014 Oct; 740():1-8. PubMed ID: 24998874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Block of cloned Kv4.3 potassium channels by dapoxetine.
    Jeong I; Kim SW; Yoon SH; Hahn SJ
    Neuropharmacology; 2012 Jun; 62(7):2261-6. PubMed ID: 22192593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of ropivacaine with cloned cardiac Kv4.3/KChIP2.2 complexes.
    Friederich P; Solth A
    Anesthesiology; 2004 Dec; 101(6):1347-56. PubMed ID: 15564942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Block of Kv4.3 potassium channel by trifluoperazine independent of CaMKII.
    Chae YJ; Choi BH; Choi JS; Hahn SJ
    Neurosci Lett; 2014 Aug; 578():159-64. PubMed ID: 24993295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of Kv4.3 voltage-dependent gating kinetics by KChIP2 isoforms.
    Patel SP; Parai R; Parai R; Campbell DL
    J Physiol; 2004 May; 557(Pt 1):19-41. PubMed ID: 14724186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosiglitazone inhibits Kv4.3 potassium channels by open-channel block and acceleration of closed-state inactivation.
    Jeong I; Choi BH; Hahn SJ
    Br J Pharmacol; 2011 Jun; 163(3):510-20. PubMed ID: 21232039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ranolazine on cloned cardiac kv4.3 potassium channels.
    Kim HJ; Ahn HS; Choi JS; Choi BH; Hahn SJ
    J Pharmacol Exp Ther; 2011 Dec; 339(3):952-8. PubMed ID: 21940646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of polyunsaturated fatty acids on Kv4/KChIP potassium channels.
    Boland LM; Drzewiecki MM; Timoney G; Casey E
    Am J Physiol Cell Physiol; 2009 May; 296(5):C1003-14. PubMed ID: 19261906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the transient outward current (Ito) in rat cardiac myocytes and human Kv4.3 channels by mefloquine.
    Perez-Cortes EJ; Islas AA; Arevalo JP; Mancilla C; Monjaraz E; Salinas-Stefanon EM
    Toxicol Appl Pharmacol; 2015 Oct; 288(2):203-12. PubMed ID: 26216464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duloxetine blocks cloned Kv4.3 potassium channels.
    Choi JS; Hahn SJ
    Brain Res; 2012 Jul; 1466():15-23. PubMed ID: 22618310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Kv4.3 potassium channels by trazodone.
    Chae YJ; Choi JS; Hahn SJ
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Aug; 386(8):711-9. PubMed ID: 23615873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of K
    de Benito-Bueno A; Socuellamos PG; Merinero YG; Cercos P; Izquierdo C; Daniel-Mozo M; Marín-Olivero I; Perez-Lara A; Gonzalez-Vera JA; Orte A; Albert A; Martin-Martinez M; Gutierrez-Rodriguez M; Valenzuela C
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Open channel block of A-type, kv4.3, and delayed rectifier K+ channels, Kv1.3 and Kv3.1, by sibutramine.
    Kim SE; Ahn HS; Choi BH; Jang HJ; Kim MJ; Rhie DJ; Yoon SH; Jo YH; Kim MS; Sung KW; Hahn SJ
    J Pharmacol Exp Ther; 2007 May; 321(2):753-62. PubMed ID: 17312186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of human Kv4.3/KChIP2 channel inactivation kinetics by cytoplasmic Ca
    Groen C; Bähring R
    Pflugers Arch; 2017 Nov; 469(11):1457-1470. PubMed ID: 28735419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of riluzole with the closed inactivated state of Kv4.3 channels.
    Ahn HS; Kim SE; Jang HJ; Kim MJ; Rhie DJ; Yoon SH; Jo YH; Kim MS; Sung KW; Hahn SJ
    J Pharmacol Exp Ther; 2006 Oct; 319(1):323-31. PubMed ID: 16815868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.